Royalty Pharma Due for Wall Street Appraisal After 70% Surge

(Bloomberg) -- Royalty Pharma Plc could get another boost on Monday when analysts weigh in for the first time following a 70% rally since last month’s trading debut.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.